ArticleEuropean journal of case reports in internal medicine2023

Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?

Gavin Ha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.